STOCK TITAN

AIM ImmunoTech to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

AIM ImmunoTech Inc. (NYSE American: AIM) announced that CEO Thomas K. Equels will present at the H.C. Wainwright Life Sciences Conference, taking place virtually on March 9-10, 2021. The presentation will be available on-demand starting March 9 at 7:00 AM Eastern Time. Registered attendees can access the webcast through the conference platform or the investor relations section of AIM's website. Additionally, management will engage in one-on-one meetings with qualified investors attending the event.

Positive
  • None.
Negative
  • None.

OCALA, Fla., March 04, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, will be presenting at the H.C. Wainwright Life Sciences Conference to be held virtually between March 9-10, 2021.

AIM’s presentation will be available on-demand to registered attendees via the conference platform beginning Tuesday, March 9, 2021, at 7:00 AM Eastern Time. The webcast will be accessible here, and the presentation will be available on the investor relations section of AIM's website at https://aimimmuno.com/events-presentations/. Management will also be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

Contacts:

Crescendo Communications, LLC
Phone: 212-671-1021
Email: aim@crescendo-ir.com

AIM ImmunoTech Inc
Phone: 800-778-4042
Email: IR@aimimmuno.com


FAQ

When is the H.C. Wainwright Life Sciences Conference 2021 for AIM ImmunoTech?

The H.C. Wainwright Life Sciences Conference will be held virtually on March 9-10, 2021.

What time does AIM ImmunoTech's presentation start at the conference?

AIM ImmunoTech's presentation will be available on-demand starting on March 9, 2021, at 7:00 AM Eastern Time.

Where can I watch AIM ImmunoTech's presentation for the conference?

You can watch AIM ImmunoTech's presentation on the conference platform or the investor relations section of their website.

Will AIM ImmunoTech be available for one-on-one meetings during the conference?

Yes, AIM ImmunoTech management will be available for one-on-one meetings with qualified investors registered for the conference.

What is AIM ImmunoTech's main focus as a company?

AIM ImmunoTech focuses on developing therapeutics for various cancers, immune disorders, and viral diseases, including COVID-19.

AIM ImmunoTech Inc.

NYSE:AIM

AIM Rankings

AIM Latest News

AIM Stock Data

13.38M
58.02M
8.57%
14.08%
0.77%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
OCALA